Volatile anesthetics affect the morphology of rat glioma C6 cells via RhoA, ERK, and Akt activation

Journal of Cellular Biochemistry

Volumn 102, Issue 2, 2007, Pages 368-376

  Tas, Piet W L ^a   Gambaryan, Stepan ^b,c   Roewer, Norbert ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Institute of Clinical Biochemistry and Pathobiochemistry   (Germany)

^c SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

Akt; C6 glioma cells; ERK; RhoA; Volatile anesthetics

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; FASUDIL; INHALATION ANESTHETIC AGENT; ISOFLURANE; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE B; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SPHINGOSINE 1 PHOSPHATE; THROMBIN;

ANIMAL CELL; ARTICLE; CELL SHAPE; CELL STRUCTURE; DRUG POTENTIATION; ENZYME ACTIVATION; FIBROBLAST; GLIOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STELLATE CELL;

RATTUS;

EID: 34948909598     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21294     Document Type: Article

References (51)

1. Alifimoff JK, Firestone LL, Miller KW. 1989. Anesthetic properties of primary alkanols: Implications for the molecular dimensions of the anesthetic site. Br J Pharmacol 96:9-16.
2. Altmayer P, Buch U, Buch HP. 1987. Direct assay of halothane in biological fluids. Naunyn Schmiedeberg's Arch Pharmacol 335(Supp 1):57.
3. Blomhoff HK, Blomhoff R, Stokke T, delange Davies C, Brevik K, Smeland EB, Funderud S, Godal T. 1988. cAMP mediated growth inhibition of a β-lymphoid precursor cell line Reh is associated with an early transient delay in G2/M followed by an accumulation of cells in Gi. J Cell Physiol 137:583-587.
4. Bodie SL, Ford I, Greaves M, Nixon GF. 2001. Thrombin-induced activation of RhoA in platelet shape change. Biochem Biophys Res Commun 287:71-76.
5. Borbiev T, Nurmukhambetova S, Liu F, Verin AD, Garcia JGN. 2000. Introduction of C3 exoenzyme into cultured endothelium by lipofectamine. Anal Biochem 285:260-264.
6. Brahmbhatt AA, Klemke RL. 2003. ERK and RhoA differentially regulate pseudopodia growth and retraction during chemotaxis. J Biol Chem 278:13016-13025.
7. Dermardirossian C, Bokoch GM. 2005. GDI's: Central regulatory molecules in Rho GTPase activation. Trends Cell Biol 15:356-363.
8. Dugan LL, Kim JS, Zhang Y, Bart RD, Sun Y, Holtzman DM, Gutmann DH. 1999. Differential effects of cAMP in neurons and astrocytes. Role of B-RAF. J Biol Chem 274:25842-25848.
9. Dumont JE, Jauniaux JC, Roger PP. 1989. The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem Sci 14:67-71.
10. Fang Z, Ionescu P, Chortkoff BS, Kandel L, Sonner J, Laster MJ, Eger EI II, 1997. Anesthetic potencies of n-alkanols: Results of additivity and solubility studies suggest a mechanism of action similar to that for conventional inhaled anesthetics. Anesth Analg 84:1042-1048.
11. 2+ sensitization of smooth muscle. FEBS Lett 440:183-187.
12. Fukata Y, Amano M, Kaibuchi K. 2001. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 22:32-39.
13. Gebbink MFBG, Kranenburg O, Poland M, van Horck FPG, Houssa B, Moolenaar WH. 1997. Identification of a novel, putative Rho-specific GDP/GTP exchange factor and a RhoA-binding protein: Control of neural morphology. J Cell Biol 137:1603-1613.
14. Hirose M, Ishizaki T, Watanabe N, Uehata M, Kranenburg O, Moolenaar WH, Matsumura F, Maekawa M, Bito H, Narumiya S. 1998. Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells. J Cell Biol 141:1625-1636.
15. Hollenberg MD, Cuatrecasas P. 1973. Epidermal growth factor: Receptors in human fibroblasts and modulation of action by cholera toxin. Proc Natl Acad Sci USA 70:2964-2968.
16. Hordijk PL, Verlaan I, Jalink K, van Corven EJ, Moolenaar WH. 1994. cAMP abrogates the p21 ras-mitogen-activated protein kinase pathway in fibroblasts. J Biol Chem 269:3534-3538.
17. Ishihara H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y, Fusetani N, Watabe S, Hashimoto K, Uemura D, Hartshorne DJ. 1989. Calyculin A and okadaic acid: Inhibitors of protein phosphatase activity. Biochem Biophys Res Commun 159:871-877.
18. Jalink K, Moolenaar WH. 1992. Thrombin receptor activation causes rapid neural cell rounding and neurite retraction independent of classic second messengers. J Cell Biol 118:411-419.
19. Jalink K, van Corven EJ, Hengeveld T, Morii N, Narumiya S, Moolenaar WH. 1994. Inhibition of lysophosphatidate-and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho. J Cell Biol 126:801-810.
20. Jo M, Thomas KS, Somlyo AV, Somlyo AP, Gonias SL. 2002. Cooperativity between the Ras-ERK and Rho-Rho kinase pathways in urokinase-type plasminogen activator-stimulated cell migration. J Biol Chem 277:12479-12485.
21. Katoh H, Negishi M, Ichikawa A. 1996. Prostaglandin E receptor EP3 subtype induce neurite retraction via small GTPase rho. J Biol Chem 271:29780-29784.
22. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuka M, Yamamoni B, Feng J, Nakano T, Okawa K, Iwamabu A, Kaibuchi K. 1996. Regulation of myosin phosphatase by Rho and Rho-associated rho kinase. Science 273:245-248.
23. Koschel K, Tas PWL. 1993. Lysophosphatidic acid reverts the β-adrenergic agonist-induced morphological response in C6 rat glioma cells. Exp Cell Res 206:162-166.
24. Kranenburg O, Poland M, van Horck FPG, Drechsel D, Hall A, Moolenaar WH. 1999. Activation of RhoA by lysophosphatidic acid and Gα12/13 subunits in neuronal cells: Induction of neurite retraction. Mol Biol Cell 10:1851-1857.
25. Ligeti E, Dagher MC, Hernandez SE, Koleske AJ, Settleman J. 2004. Phospholipids can switch the GTPase substrate preference of a GTPase-activating protein. J Biol Chem 279:5055-5058.
26. Majumdar M, Seasholtz TM, Goldstein D, de Lanerolle P, Heller-Brown J. 1998. Requirement for rho-mediated light chain phosphorylation in thrombin-stimulated cell rounding and its dissociation from mitogenesis. J Biol Chem 273:10099-10106.
27. Manning TJ Jr, Rosenfeld SS, Sontheimer H. 1998. Lysophosphatidic acid stimulates actomyosin contraction in astrocytes. J Neurosci Res 53:343-352.
28. Mark MD, Storm DR. 1997. Coupling of epidermal growth factor (EGF) with the antiproliferative activity of cAMP induces neuronal differentiation. J Biol Chem 272:17238-17244.
29. Mazze RI, Rice SA, Baden JM. 1985. Halothane, isoflurane and enflurane MAC in pregnant and non-pregnant female and male mice and rats. Anesthesiology 62:339-341.
30. Meyer H. 1899. Theorie der Alkoholnarkose. Arch Exp Pathol Pharmakol 42:109-118.
31. A and glycine receptors. Nature 389:385-389.
32. Narumiya S. 1996. The small GTPase Rho: Cellular functions and signal transmission. J Biochem 120:215-228.
33. Nicole O, Goldshmidt A, Hamill CE, Sorensen SD, Sastre A, Lyuboslavsky P, Hepler JR, Mckeon RJ, Traynelis SF. 2005. Activation of protease-activated receptor-1 triggers astrogliosis after brain injury. J Neurosci 25:4319-4329.
34. Nilsson J, Olsson AG. 1984. Prostaglandin E1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. Atherosclerosis 53:77-82.
35. Nobes CD, Hall A. 1995. Rho, rac and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81:53-62.
36. Oey J. 1975. Noradrenaline induces morphological alterations in nucleated and enucleated rat C6 glioma cells. Nature 257:317-319.
37. Ohkawara H, Ishibashi T, Sakamoto T, Sugimoto K, Nagata K, Yokoyama K, Sakamoto N, Kamioka M, Matsuoka I, Fukuhara S, Sugimoto N, Takuwa Y, Maruyama Y. 2005. Thrombin-induced rapid geranylgeranylation of RhoA as an essential process for RhoA activation in endothelial cells. J Biol Chem 280:10182-10188.
38. Pan ZZ, Bruening W, Godwin AK. 2006. Involvement of Rho GTPases and ERK in synuclein-gamma enhanced cancer cell motility. Int J Oncol 29:1201-1205.
39. Pang H, Guo Z, Su W, Xie Z, Eto M, Gong MC. 2005. RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor CPI-17 in vascular smooth muscle cells. Am J Physiol Cell Physiol 289:C352-C360.
40. Rottner K, Hall A, Small JV. 1999. Interplay between Rac and Rho in the control of substrate contact dynamics. Curr Biol 9:640-648.
41. Sahai E, Olson MF, Marshall CJ. 2001. Cross-talk between Ras and Rho signaling pathways in transformation favours proliferation and increased molality. EMBO J 20:755-766.
42. Seasholtz TM, Radeff-Huang J, Sagi SA, Matteo R, Weems JM, Stoudt Cohen A, Feramisco JR, Heller-Brown J. 2004. Rho-mediated cytoskeletal rearrangement in response to LPA is functionally antagonized by Rac 1 and P IP2. J Neurochem 91:501-512.
43. Schmitt JM, Stork PJ. 2001. Cyclic AMP-mediated inhibition of cell growth requires the small G-protein Rap 1. Mol Cell Biol 21:3671-3683.
44. Smolenski A, Bachmann C, Reinhard K, Honig-Liedl P, Jarchau T, Hoschuetzky H, Walter U. 1998. Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J Biol Chem 273:20029-20035.
45. Somlyo AP, Somlyo AV. 2000. Signal transduction by G proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522:177-185.
46. Sörensen SD, Nicole O, Peavy RD, Montoya LM, Lee J, Murphy TJ, Traynelis SF, Hepler JR. 2003. Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation in astrocytes. Mol Pharmacol 64:1199-1209.
47. Tas PWL, Koschel K. 1990. Thrombin revert the β-adrenergic agonist-induced morphological response in rat glioma C6 cells. Exp Cell Res 188:22-27.
48. 2+-ion concentration. Biochim Biophys Acta 1091:401-404.
49. 2+ signal and shape changes in rat glioma C6 cells. J Neurosci Res 52:427-434.
50. Uehata M, Ishizuki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S. 1997. Calcium sensitization of smooth muscle mediated by Rho-associated protein kinase in hypertension. Nature 389:990-994.
51. Wang L, Liu F, Adamo MI. 2001. Cyclic AMP inhibits extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways by inhibiting Rap1. J Biol Chem 276:37242-37249.